- 全部删除
您的购物车当前为空
Grisnilimab(WT1)是一种靶向CD7的单克隆抗体。CD7在T细胞和T细胞/ B细胞相互作用中起重要作用,Wilms ' tumor 1 (WT1)基因在白血病和各种类型的实体瘤(如肺癌和结直肠癌)中过表达。
Grisnilimab(WT1)是一种靶向CD7的单克隆抗体。CD7在T细胞和T细胞/ B细胞相互作用中起重要作用,Wilms ' tumor 1 (WT1)基因在白血病和各种类型的实体瘤(如肺癌和结直肠癌)中过表达。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 2,480 | In stock | |
| 5 mg | ¥ 5,860 | In stock | |
| 10 mg | ¥ 7,890 | In stock | |
| 25 mg | ¥ 11,700 | In stock |
Grisnilimab 相关产品
| 产品描述 | Grisnilimab (WT1) is a monoclonal antibody targeting CD7. CD7 plays a crucial role in T cell and T cell/B cell interactions, and the Wilms' tumour 1 (WT1) gene is overexpressed in leukaemia and various types of solid tumours (such as lung cancer and colorectal cancer). |
| 别名 | WT1, WT 1 |
| CAS No. | 2367001-70-3 |
| 存储 | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容